U.S. Markets closed

Fulcrum Therapeutics, Inc. (FULC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.440.00 (0.00%)
At close: 4:00PM EDT
8.44 0.00 (0.00%)
After hours: 04:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 322.39
52 Week Low 37.01
50-Day Moving Average 39.82
200-Day Moving Average 311.68

Share Statistics

Avg Vol (3 month) 390.04k
Avg Vol (10 day) 366.22k
Shares Outstanding 532.68M
Implied Shares Outstanding 6N/A
Float 19.53M
% Held by Insiders 129.74%
% Held by Institutions 167.89%
Shares Short (Apr 14, 2021) 4771.11k
Short Ratio (Apr 14, 2021) 47.11
Short % of Float (Apr 14, 2021) 44.34%
Short % of Shares Outstanding (Apr 14, 2021) 42.36%
Shares Short (prior month Mar 14, 2021) 4704.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-811.64%

Management Effectiveness

Return on Assets (ttm)-37.29%
Return on Equity (ttm)-77.68%

Income Statement

Revenue (ttm)8.82M
Revenue Per Share (ttm)0.35
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-46.84M
EBITDA -69.23M
Net Income Avi to Common (ttm)-70.82M
Diluted EPS (ttm)-14.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)112.91M
Total Cash Per Share (mrq)3.47
Total Debt (mrq)17k
Total Debt/Equity (mrq)0.02
Current Ratio (mrq)4.47
Book Value Per Share (mrq)4.53

Cash Flow Statement

Operating Cash Flow (ttm)-53.66M
Levered Free Cash Flow (ttm)-24.98M